Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Inês BERNARDINO |
Documents disponibles écrits par cet auteur (1)
Faire une suggestion Affiner la recherche
Training the social brain: Clinical and neural effects of an 8-week real-time functional magnetic resonance imaging neurofeedback Phase IIa Clinical Trial in Autism / Bruno DIREITO in Autism, 26-6 (August 2022)
[article]
Titre : Training the social brain: Clinical and neural effects of an 8-week real-time functional magnetic resonance imaging neurofeedback Phase IIa Clinical Trial in Autism Type de document : Texte imprimé et/ou numérique Auteurs : Bruno DIREITO, Auteur ; Susana MOUGA, Auteur ; Alexandre SAYAL, Auteur ; Marco SIMOES, Auteur ; Hugo QUENTAL, Auteur ; Inês BERNARDINO, Auteur ; Rebecca PLAYLE, Auteur ; Rachel MCNAMARA, Auteur ; David Ej LINDEN, Auteur ; Guiomar OLIVEIRA, Auteur ; Miguel CASTELO BRANCO, Auteur Article en page(s) : p.1746-1760 Langues : Anglais (eng) Mots-clés : Autism Spectrum Disorder/diagnostic imaging/therapy Autistic Disorder/diagnostic imaging/therapy Brain/diagnostic imaging Humans Magnetic Resonance Imaging Neurofeedback autism spectrum disorder neurofeedback neurorehabilitation posterior superior temporal sulcus real-time functional magnetic resonance imaging social cognition Index. décimale : PER Périodiques Résumé : Neurofeedback is an emerging therapeutic approach in neuropsychiatric disorders. Its potential application in autism spectrum disorder remains to be tested. Here, we demonstrate the feasibility of real-time functional magnetic resonance imaging volitional neurofeedback in targeting social brain regions in autism spectrum disorder. In this clinical trial, autism spectrum disorder patients were enrolled in a program with five training sessions of neurofeedback. Participants were able to control their own brain activity in this social brain region, with positive clinical and neural effects. Larger, controlled, and blinded clinical studies will be required to confirm the benefits. En ligne : http://dx.doi.org/10.1177/13623613211002052 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=484
in Autism > 26-6 (August 2022) . - p.1746-1760[article] Training the social brain: Clinical and neural effects of an 8-week real-time functional magnetic resonance imaging neurofeedback Phase IIa Clinical Trial in Autism [Texte imprimé et/ou numérique] / Bruno DIREITO, Auteur ; Susana MOUGA, Auteur ; Alexandre SAYAL, Auteur ; Marco SIMOES, Auteur ; Hugo QUENTAL, Auteur ; Inês BERNARDINO, Auteur ; Rebecca PLAYLE, Auteur ; Rachel MCNAMARA, Auteur ; David Ej LINDEN, Auteur ; Guiomar OLIVEIRA, Auteur ; Miguel CASTELO BRANCO, Auteur . - p.1746-1760.
Langues : Anglais (eng)
in Autism > 26-6 (August 2022) . - p.1746-1760
Mots-clés : Autism Spectrum Disorder/diagnostic imaging/therapy Autistic Disorder/diagnostic imaging/therapy Brain/diagnostic imaging Humans Magnetic Resonance Imaging Neurofeedback autism spectrum disorder neurofeedback neurorehabilitation posterior superior temporal sulcus real-time functional magnetic resonance imaging social cognition Index. décimale : PER Périodiques Résumé : Neurofeedback is an emerging therapeutic approach in neuropsychiatric disorders. Its potential application in autism spectrum disorder remains to be tested. Here, we demonstrate the feasibility of real-time functional magnetic resonance imaging volitional neurofeedback in targeting social brain regions in autism spectrum disorder. In this clinical trial, autism spectrum disorder patients were enrolled in a program with five training sessions of neurofeedback. Participants were able to control their own brain activity in this social brain region, with positive clinical and neural effects. Larger, controlled, and blinded clinical studies will be required to confirm the benefits. En ligne : http://dx.doi.org/10.1177/13623613211002052 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=484